Literature DB >> 20458624

Peripheral arthritis in the course of inflammatory bowel diseases.

Ilhami Yüksel1, Hilmi Ataseven, Omer Başar, Seyfettin Köklü, Ibrahim Ertuğrul, Aysel Ulker, Ulkü Dağlı, Nurgül Saşmaz.   

Abstract

BACKGROUND: Musculoskeletal disorders are well-defined extra-intestinal manifestations of inflammatory bowel diseases (IBD). There is little data regarding the frequencies of IBD and extra-intestinal manifestations from Central and East Europe and Middle Eastern countries. AIMS: To determine the prevalence of peripheral arthritis in IBD and to document the relationship to other extra-intestinal manifestations.
METHODS: Enrolled in the study were 357 patients who were diagnosed with IBD from December 2002 through January 2008. All of the patients underwent a detailed whole-body examination by a gastroenterologist and rheumatologist.
RESULTS: IBD-related peripheral arthritis (IBDPA) was found in 66 (18.5%) of the 357 patients (28.3% Crohn's disease, 13.5% ulcerative colitis; p=0.001 χ=11.62). IBDPA was more frequent in female patients (60.6 vs. 39.4%, p=0.000, χ=11.12). In eight (12.1%) cases, IBDPA occurred before the onset of IBD. Acute self-limiting episodes, recurrences of the attacks, and persistent symptoms of arthritis were present in 40 (60.6%), 26 (39.3%), and 29 (45.7%) patients, respectively. Arthritis was symmetrical in 33 (50%) cases. Knees (65.2%) and ankles (62.1%) were the most commonly affected joints. Erythema nodosum and pyoderma gangrenosum were more common among patients with IBDPA than patients without it (p=0.001, χ=10.49, and p=0.000 χ=25.77, respectively).
CONCLUSIONS: IBDPA is a frequent extra-intestinal complication of IBD. Those of female gender and the presence of Crohn's disease, erythema nodosum and pyoderma gangrenosum have a higher risk to develop IBDPA.

Entities:  

Mesh:

Year:  2010        PMID: 20458624     DOI: 10.1007/s10620-010-1260-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  The musculo-skeletal complications of Crohn's disease.

Authors:  I Haslock; V Wright
Journal:  Medicine (Baltimore)       Date:  1973-05       Impact factor: 1.889

2.  Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation.

Authors:  H Mielants; E M Veys; K Goethals; C Van Der Straeten; C Ackerman
Journal:  Clin Exp Rheumatol       Date:  1990 Jan-Feb       Impact factor: 4.473

3.  Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history.

Authors:  T R Orchard; B P Wordsworth; D P Jewell
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

4.  The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Authors:  Nuran Turkcapar; Murat Toruner; Irfan Soykan; Olcay Tiryaki Aydintug; Hulya Cetinkaya; Nursen Duzgun; Ali Ozden; Murat Duman
Journal:  Rheumatol Int       Date:  2005-09-01       Impact factor: 2.631

Review 5.  Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease.

Authors:  B Schorr-Lesnick; L J Brandt
Journal:  Am J Gastroenterol       Date:  1988-03       Impact factor: 10.864

6.  An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors.

Authors:  A Calin; J F Fries
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

Review 7.  Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn's disease.

Authors:  J T Gran; G Husby
Journal:  Dig Dis       Date:  1992       Impact factor: 2.404

8.  Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey.

Authors:  Nurdan Tozun; Ozlen Atug; Nese Imeryuz; Hulya O Hamzaoglu; Arzu Tiftikci; Erkan Parlak; Ulku Dagli; Aysel Ulker; Sadettin Hulagu; Hale Akpinar; Candan Tuncer; Inci Suleymanlar; Oya Ovunc; Fatih Hilmioglu; Serap Aslan; Kursat Turkdogan; Halil Ibrahim Bahcecioglu; Cihan Yurdaydin
Journal:  J Clin Gastroenterol       Date:  2009-01       Impact factor: 3.062

9.  Mucocutaneous manifestations in inflammatory bowel disease.

Authors:  Ilhami Yüksel; Omer Başar; Hilmi Ataseven; Ibrahim Ertuğrul; Mehmet Arhan; Mehmet Ibiş; Ulkü Dağli; Bilge Tunç Demirel; Aysel Ulker; Sema Seçilmiş; Nurgül Saşmaz
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

Review 10.  Review article: bone and joint diseases in inflammatory bowel disease.

Authors:  M De Vos; F De Keyser; H Mielants; C Cuvelier; E Veys
Journal:  Aliment Pharmacol Ther       Date:  1998-05       Impact factor: 8.171

View more
  13 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

2.  Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

3.  Inflammatory bowel disease in Chinese children: A retrospective analysis of 49 cases.

Authors:  Ying Zhou; Ying Huang
Journal:  Exp Ther Med       Date:  2016-09-28       Impact factor: 2.447

4.  Inflammatory bowel disease associated arthropathy.

Authors:  Sheila L Arvikar; Mark C Fisher
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

5.  The association between pulmonary function impairment and colon inflammation in ulcerative colitis patients: A scientific basis for exterior-interior correlation between lung and large intestine.

Authors:  Jian-Yun Wang; Xin-Yue Wang; Hua-Yang Wu; Hui-Yi Sun; Da-Ming Liu; Wen Zhang; Chen-Xi Jin; Shuo-Ren Wang
Journal:  Chin J Integr Med       Date:  2014-06-18       Impact factor: 1.978

Review 6.  Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology.

Authors:  Rodolfo Perez-Alamino; Hernan Maldonado-Ficco; José A Maldonado-Cocco
Journal:  Clin Rheumatol       Date:  2015-11-17       Impact factor: 2.980

7.  Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.

Authors:  Alicia Algaba; Iván Guerra; Elena Ricart; Eva Iglesias; Miriam Mañosa; Javier P Gisbert; Jordi Guardiola; Miguel Mínguez; Beatriz Castro; Ruth de Francisco; Pilar Nos; Federico Bertoletti; Francisco Mesonero; Jesús Barrio; María Dolores Martín-Arranz; Xavier Calvet; Santiago García-López; Beatriz Sicilia; Gillermo Alcaín; María Esteve; Lucía Márquez; Marta Piqueras; Laura Jiménez; José L Perez-Calle; Luis Bujanda; Mariana García-Sepulcre; Alejandra Fernández; Irene Moraleja; Rufo Humberto Lorente; Orlando García-Bosch; Ana Lambán; Isabel Blázquez; Esther Rodríguez; José M Huguet; Alfredo J Lucendo; Pedro Almela; David Busquets; Patricia Ramírez de la Piscina; Marcela Pérez; Eugeni Domenech; Fernando Bermejo
Journal:  Dig Dis Sci       Date:  2020-07-15       Impact factor: 3.199

8.  Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study.

Authors:  João Rovisco; Cátia Duarte; Alberto Batticcioto; Piercarlo Sarzi-Puttini; Antonella Dragresshi; Francisco Portela; Marwin Gutierrez
Journal:  BMC Musculoskelet Disord       Date:  2016-02-16       Impact factor: 2.362

9.  Relationship between articular and nonarticular manifestations in inflammatory bowel diseases.

Authors:  Alimohammad Fatemi; Hourossadat Hashemi Jazi; Mohammad Hasan Emami; Amir Kazemizadeh; Hamid Tavakkoli; Abbas Smiley
Journal:  J Res Med Sci       Date:  2016-06-14       Impact factor: 1.852

Review 10.  Enteropathic spondyloarthritis: from diagnosis to treatment.

Authors:  Rosario Peluso; Matteo Nicola Dario Di Minno; Salvatore Iervolino; Francesco Manguso; Giuseppina Tramontano; Pasquale Ambrosino; Carmela Esposito; Antonella Scalera; Fabiana Castiglione; Raffaele Scarpa
Journal:  Clin Dev Immunol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.